New York City, NY -- (SBWIRE) -- 10/17/2013 -- StockMarketIntel.com issues a special report on the following stocks: Abraxas Petroleum Corp. (NASDAQ:AXAS), Real Goods Solar, Inc. (NASDAQ:RSOL), Coronado Biosciences Inc (NASDAQ:CNDO), Emerald Oil Inc (NYSEMKT:EOX)
Abraxas Petroleum Corp. (NASDAQ:AXAS) gained 1.91%, trading on 2.17 million shares, to end the trade at $2.93. The stock changed hands in a range of $2.88 to $3.00, bringing its market capitalization to about $272.37 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $1.55 and was moved to the maximum level of $3.04. Abraxas Petroleum Corporation is an independent energy company primarily engaged in the acquisition, exploitation, development and production of oil and gas in the United States and Canada. As of December 31, 2011, the Company’s estimated net proved reserves were 29.0 million barrels of oil equivalent (MMBoe), (including reserves attributable to its 34.7% equity interest in the proved reserves of Blue Eagle), of which 53% were classified as proved developed, 54% were oil and natural gas liquids (NGL’s) and 94% by PV-10 were operated. Its daily net production during the year ended December 31, 2011, was 3,484 barrels of oil equivalent per day, of which 45% was oil or liquids.
Why Should Investors Buy AXAS After The Recent Gain? Just Go Here and Find Out
Real Goods Solar, Inc. (NASDAQ:RSOL) added 2.59%, to complete the trading session at $2.77, with a total volume of 2.11 million shares. The stock, on average, trades on a volume of 2.26 million shares. It floated in a range of $2.68 to $2.83 during the last trading session, with a beta value of 1.02. Its market capitalization now moved to about $83.76 million. In the past 52 weeks, the share price has not declined below $0.40 and above $7.17. Real Goods Solar, Inc. is a solar energy company serving the commercial, residential and utility customers. As of February 5, 2013, the Company had installed more than 14,500 solar power systems representing over 100 megawatts of 100% renewable energy.
What was the Moving Force behind RSOL on Bullish Run? Read This Research Report
Coronado Biosciences Inc (NASDAQ:CNDO) added 5.81% and was in a range of $1.70-$1.88 before closing at $1.82. The stock completed the day with a total volume of 1.93 million shares, versus an average volume of 1.56 million shares. The share price hit its 52-week low of $1.68 and $12.70 was the best price. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML).
For How Long CNDO will fight for Profitability? Read This Trend Analysis report
Emerald Oil Inc (NYSEMKT:EOX) added5.36% yesterday, bringing its market capitalization around $479.93 million. The share price, after opening at $7.30, made a high of $7.78 and hovered above $7.21 to end the day at $7.67. The total number of shares that changed hands during the session was 1.88 million shares, as compared to average trading volume of 1.09 million shares. Emerald Oil, Inc. (Emerald) is an independent oil and natural gas exploration and production company. It focuses on developing oil wells in the Williston Basin of North Dakota and Montana primarily targeting the Bakken and three forks shale oil formations. It controls approximately 35,000 net acres in the Williston Basin. In addition to its Williston Basin position, Emerald holds positions in the Rocky Mountain oil and natural gas plays.
For How Long EOX Gloss will Attract Investors? Find out via this report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)